Insights into US public biotech sector using patenting trends

Article Abstract:

An analysis of the trends in patenting by publicly traded biotech firms in the decade 1995-2005 from the data collected by US Patent and Trade Organization (USPTO) website is presented. The study shows the growing importance of public small-and medium-sized enterprises (SMEs), compared with large biotech firms, in developing the intellectual property (IP) knowledge base.

---

Navigating the future(s) of biotech intellectual property

Article Abstract:

The role of intellectual property (IP) in biotech is gaining utmost importance as the sector faces the need both to protect innovations and to open them up. The risk to the biotech industry will increase if the public and nonprofit sector will put together pressure for bigger changes in the patent system.

---

Trendspotting: A shift in intellectual property focus

Article Abstract:

Developments in intellectual property and their effect on the life science industry are reported. The diverse legal issues in financings, licensing and collaboration transactions, and the intellectual property protection and strategies that life science companies and investors face is addressed.

Financial management, Finance, Company financing

Similar abstracts:

• Abstracts: Antiinfective biotechs face partnering gap. A taste of the future
• Abstracts: Toll-like receptor therapies compete to reduce side effects. Belated approval of first recombinant protein from animal
• Abstracts: Robert Tjian. Tracking down tissues. Cellulosic ethanol booms despite unproven business models
• Abstracts: Gold in the ivory tower: Equity rewards of outlicensing. Who took the tech out of biotech? The hermit crab solution

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.